UK markets close in 8 hours 18 minutes

Immunovia AB (publ) (0G8X.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
1.4000-0.0680 (-4.63%)
As of 11:13AM BST. Market open.
Currency in SEK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.73
52-week change 3-81.17%
S&P500 52-week change 321.08%
52-week high 37.8250
52-week low 30.0000
50-day moving average 31.7083
200-day moving average 32.5836

Share statistics

Avg vol (3-month) 321.02k
Avg vol (10-day) 319.32k
Shares outstanding 519.53M
Implied shares outstanding 6N/A
Float 838.37M
% held by insiders 124.48%
% held by institutions 12.29%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-15,136.77%

Management effectiveness

Return on assets (ttm)-92.88%
Return on equity (ttm)-199.13%

Income statement

Revenue (ttm)1.57M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)-69.10%
Gross profit (ttm)N/A
EBITDA -154.97M
Net income avi to common (ttm)-309.44M
Diluted EPS (ttm)-7.8050
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)76.79M
Total cash per share (mrq)1.7
Total debt (mrq)10.27M
Total debt/equity (mrq)15.32%
Current ratio (mrq)2.69
Book value per share (mrq)1.48

Cash flow statement

Operating cash flow (ttm)-147.06M
Levered free cash flow (ttm)-48.74M